ACTIVE

ROCHE DIAGNOSTICS BELGIUM

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

1,2 M €

-38.7% YoY

Revenue

131,2 M €

+1.3% YoY

Equity

36,2 M €

+3.5% YoY

Workforce

187,3 ETP

+1.7% YoY

What does ROCHE DIAGNOSTICS BELGIUM do?

ROCHE DIAGNOSTICS BELGIUM is a Public limited company incorporated in 1958. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Machelen (Brab.). It employs on average 187,3 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0403.049.945

Incorporation

07/11/1958

Legal form

Public limited company

Registered office

Berkenlaan 8A box 8
1831 Machelen (Brab.) · FlandreSee on map

Contributed capital

3 750 000,00 €

Latest accounts

31/12/2025

Average workforce

187,3 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 51460Air transport

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008
Income statement
Revenue	131,2 M €	+1.3%	129,6 M €	-0.2%	129,8 M €	-2.6%	133,3 M €	-14.6%	156,2 M €	+19.3%	130,9 M €	+7.7%	121,5 M €	+2.8%	118,2 M €	+0.5%	117,6 M €	+4.8%	112,2 M €	+3.4%	108,5 M €	+3.6%	104,7 M €	+3.7%	101 M €	+4.0%	97,1 M €	+5.9%	91,7 M €	-2.2%	93,8 M €	+6.9%	87,8 M €	+5.7%	83 M €
EBITDA	14,3 M €	+1.6%	14,1 M €	-9.9%	15,6 M €	+8.1%	14,5 M €	-14.9%	17 M €	+14.8%	14,8 M €	+5.6%	14 M €	+18.5%	11,8 M €	-17.1%	14,3 M €	-3.3%	14,8 M €	+15.9%	12,7 M €	-0.4%	12,8 M €	-2.5%	13,1 M €	+11.1%	11,8 M €	+27.0%	9,3 M €	-5.7%	9,9 M €	+34.9%	7,3 M €	+10.9%	6,6 M €
Operating result	3,6 M €	-18.6%	4,4 M €	-33.6%	6,7 M €	+12.1%	6 M €	+1.2%	5,9 M €	-4.3%	6,2 M €	+41.1%	4,4 M €	+52.3%	2,9 M €	-33.7%	4,3 M €	-1.7%	4,4 M €	+60.2%	2,7 M €	+7.4%	2,6 M €	-23.7%	3,3 M €	-7.2%	3,6 M €	+35.9%	2,7 M €	-32.8%	4 M €	+44.3%	2,7 M €	+5.0%	2,6 M €
Net result	1,2 M €	-38.7%	2 M €	-42.7%	3,5 M €	-10.3%	3,9 M €	+29.6%	3 M €	-20.4%	3,7 M €	+73.4%	2,2 M €	+122%	971 k €	-37.5%	1,6 M €	-25.8%	2,1 M €	+68.8%	1,2 M €	+38.2%	898,2 k €	-47.3%	1,7 M €	-14.5%	2 M €	+36.1%	1,5 M €	-37.0%	2,3 M €	+61.5%	1,4 M €	-6.0%	1,5 M €
Balance sheet
Equity	36,2 M €	+3.5%	35 M €	+6.0%	33 M €	+11.7%	29,5 M €	+15.1%	25,6 M €	+13.1%	22,7 M €	+19.8%	18,9 M €	+12.9%	16,8 M €	-15.3%	19,8 M €	+8.5%	18,2 M €	-13.7%	21,1 M €	+6.2%	19,9 M €	-17.1%	24 M €	+7.6%	22,3 M €	+9.8%	20,3 M €	+7.8%	18,8 M €	+14.1%	16,5 M €	+9.5%	15,1 M €
Total assets	64 M €	+1.4%	63,1 M €	+5.0%	60,1 M €	+5.5%	57 M €	-1.7%	58 M €	+3.7%	55,9 M €	+1.3%	55,2 M €	+12.8%	48,9 M €	-5.4%	51,7 M €	+4.7%	49,4 M €	+7.9%	45,8 M €	-7.3%	49,4 M €	-2.0%	50,4 M €	+2.9%	48,9 M €	+18.8%	41,2 M €	+1.9%	40,4 M €	-2.6%	41,5 M €	+14.2%	36,4 M €
Cash	0 €		0 €	-100%	3 M €	+141376%	2,1 k €	-99.9%	2,6 M €	+118327%	2,2 k €	0.0%	2,2 k €	-41.8%	3,8 k €	+18.2%	3,2 k €	+567%	482,4 €	-64.0%	1,3 k €	-99.9%	1,8 M €	+144249%	1,3 k €	-84.1%	8 k €	+28.8%	6,2 k €	-99.8%	3,2 M €	+1.9%	3,1 M €	+4.1%	3 M €
Debts	24,5 M €	-5.6%	25,9 M €	+6.7%	24,3 M €	-6.8%	26 M €	-15.6%	30,9 M €	-3.2%	31,9 M €	-8.5%	34,9 M €	+14.4%	30,5 M €	+3.3%	29,5 M €	+2.2%	28,9 M €	+30.3%	22,2 M €	-17.2%	26,8 M €	+12.1%	23,9 M €	-2.7%	24,5 M €	+27.3%	19,3 M €	-5.8%	20,4 M €	-16.2%	24,4 M €	+17.7%	20,7 M €
Other
Workforce	187,3 ETP	+1.7%	184,2 ETP	-1.0%	186,1 ETP	+1.1%	184,1 ETP	-0.3%	184,7 ETP	-1.2%	186,9 ETP	+1.6%	184,0 ETP	+2.1%	180,3 ETP	+1.9%	176,9 ETP	+5.9%	167,1 ETP	+2.5%	163,1 ETP	+4.7%	155,8 ETP	+1.2%	153,9 ETP	+3.3%	149,0 ETP	+2.6%	145,2 ETP	-0.3%	145,7 ETP	+0.3%	145,3 ETP	+6.0%	137,1 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 55 ended

Active mandates

Borst Maria Johanna

Director · since 01 juillet 2022

Active

Decker Isabelle

Managing director · since 01 juillet 2022

Active

Bernard Colombo

Director · since 05 avril 2019

Active

Ended mandates

Borst Maria Johanna

Director · since 01 juillet 2022 · until 27 juin 2023

Ended

Decker Isabelle

Managing director · since 01 juillet 2022 · until 27 juin 2023

Ended

Bernard COLOMBO

Director · since 29 juin 2022 · until 27 juin 2023

Ended

Carsten ARNT

Director · since 01 mars 2022 · until 29 juin 2022

Ended

At this address

Other companies at this address

Company	CBE no.
CAZIMIR● Active	0819.828.459
Colt Technology Services● Active	0461.455.625

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	09/06/2026	17/06/2025	29/07/2024	30/06/2023	29/08/2022	22/06/2021
General meeting	04/06/2026	05/06/2025	12/07/2024	27/06/2023	29/06/2022	28/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	04/06/2026	09/06/2026	Dutch	PDF
Full model	31/12/2024	05/06/2025	17/06/2025	Dutch	PDF
Full model	31/12/2023	12/07/2024	29/07/2024	Dutch	PDF
Full model	31/12/2022	27/06/2023	30/06/2023	Dutch	PDF
Full model	31/12/2021	29/06/2022	29/08/2022	Dutch	PDF
Full model	31/12/2020	28/05/2021	22/06/2021	Dutch	PDF
Full model	31/12/2019	28/04/2020	11/06/2020	Dutch	PDF
Full model	31/12/2018	05/04/2019	08/05/2019	Dutch	PDF
Full model	31/12/2017	24/04/2018	23/05/2018	Dutch	PDF
Full model	31/12/2016	04/04/2017	11/05/2017	Dutch	PDF
Full model	31/12/2015	26/04/2016	12/05/2016	Dutch	PDF
Full model	31/12/2014	28/04/2015	28/05/2015	Dutch	PDF
Full model	31/12/2013	22/04/2014	22/05/2014	Dutch	PDF
Full model	31/12/2012	16/04/2013	14/05/2013	Dutch	PDF
Full model	31/12/2011	17/04/2012	29/05/2012	Dutch	PDF
Full model	31/12/2010	05/04/2011	12/05/2011	Dutch	PDF
Full model	31/12/2009	06/04/2010	25/05/2010	Dutch	PDF
Full model	31/12/2008	07/04/2009	05/05/2009	Dutch	PDF
Full model	31/12/2007	01/04/2008	05/05/2008	Dutch	PDF
Full model	31/12/2006	03/04/2007	04/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 55 ended

Active mandates

Borst Maria Johanna

Director · since 01 juillet 2022

Active

Decker Isabelle

Managing director · since 01 juillet 2022

Active

Bernard Colombo

Director · since 05 avril 2019

Active

Ended mandates

Borst Maria Johanna

Director · since 01 juillet 2022 · until 27 juin 2023

Ended

Decker Isabelle

Managing director · since 01 juillet 2022 · until 27 juin 2023

Ended

Bernard COLOMBO

Director · since 29 juin 2022 · until 27 juin 2023

Ended

Carsten ARNT

Director · since 01 mars 2022 · until 29 juin 2022

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates27/08/2026
DELEGATIE BIJZONDERE VOLMACHTEN - ONTSLAG - BENOEMING
PDF
Mandates28/11/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates01/08/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates12/08/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates06/05/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates19/04/2024
ONTSLAGEN - BENOEMINGEN
PDF
Other19/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates30/11/2023
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 20251,2 M €↓
14/10/2025
reconductionEllemarie Bex — commissaris
05/06/2025
reconductionBernard Colombo — Bestuurder
05/06/2025
reconductionIsabelle Decker — Afgevaardigd Bestuurder
05/06/2025
reconductionMaria Johanna Borst — Bestuurder
2024
Annual accounts 20242 M €↓
12/07/2024
reconductionBernard Colombo — Bestuurder
12/07/2024
reconductionIsabelle Decker — Afgevaardigd Bestuurder
12/07/2024
reconductionMaria Borst — Bestuurder
2023
Annual accounts 20233,5 M €↓
19/07/2023
nominationAnnelies Van Buyten — bijzonder gevolmachtigde voor handtekeningbevoegdheid voor wat betreft het dagelijks bestuur
27/06/2023
nominationJoris Beke — bijzonder gevolmachtigde voor handtekeningbevoegdheid voor wat betreft het dagelijks bestuur
27/06/2023
reconductionChristophe Chausteur — bijzonder gevolmachtigde voor handtekeningbevoegdheid om documenten te ondertekenen met betrekking tot de Belgische Diabetes Care activiteiten
27/06/2023
reconductionWim Vandewalle — bijzonder gevolmachtigde voor handtekeningbevoegdheid om documenten te ondertekenen met betrekking tot de Belgische Diabetes Care activiteiten
27/06/2023
reconductionThierry Hernould — bijzonder gevolmachtigde voor handtekeningbevoegdheid om documenten te ondertekenen met betrekking tot de Belgische Diabetes Care activiteiten
27/06/2023
reconductionEva Sinjan — bijzonder gevolmachtigde voor handtekeningbevoegdheid om documenten te ondertekenen met betrekking tot de Belgische Diabetes Care activiteiten
27/06/2023
reconductionHenrique Zorn — bijzonder gevolmachtigde voor handtekeningbevoegdheid om documenten te ondertekenen met betrekking tot de Belgische Diabetes Care activiteiten
27/06/2023
reconductionBernard Colombo — Bestuurder
27/06/2023
reconductionIsabelle Decker — Afgevaardigd Bestuurder
27/06/2023
reconductionMaria Johanna Borst — Bestuurder
2022
Annual accounts 20223,9 M €↑
01/07/2022
nominationMaria Johanna Borst — bestuurder
01/07/2022
nominationIsabelle Decker — bestuurder
01/05/2022
nominationJoris Beke Smets — lid van het directiecomité
2021
Annual accounts 20213 M €↓
2020
Annual accounts 20203,7 M €↑
2019
Annual accounts 20192,2 M €↑
2018
Annual accounts 2018971 k €↓
2017
Annual accounts 20171,6 M €↓
2016
Annual accounts 20162,1 M €↑
2015
Annual accounts 20151,2 M €↑
2014
Annual accounts 2014898,2 k €↓
2013
Annual accounts 20131,7 M €↓
2012
Annual accounts 20122 M €↑
2011
Annual accounts 20111,5 M €↓
2010
Annual accounts 20102,3 M €↑
2009
Annual accounts 20091,4 M €↓
2008
Annual accounts 20081,5 M €
07/11/1958
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

ROCHE DIAGNOSTICS BELGIUM

Overview

What does ROCHE DIAGNOSTICS BELGIUM do?

Trend over 18 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline